Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

被引：0

作者：

Aakash Desai

Justin F. Gainor

Aparna Hegde

Alison M. Schram

Giuseppe Curigliano

Sumanta Pal

Stephen V. Liu

Balazs Halmos

Roman Groisberg

Enrique Grande

Tomislav Dragovich

Marc Matrana

Neeraj Agarwal

Sant Chawla

Shumei Kato

Gilberto Morgan

Pashtoon M. Kasi

Benjamin Solomon

Herbert H. Loong

Haeseong Park

Toni K. Choueiri

Ishwaria M. Subbiah

Naveen Pemmaraju

Vivek Subbiah

机构：

[1] Mayo Clinic College of Medicine,Division of Medical Oncology

[2] Massachusetts General Hospital,Department of Medicine

[3] University of Alabama at Birmingham,Department of Hematology and Oncology, O’Neal Comprehensive Cancer Center

[4] Memorial Sloan Kettering Cancer Center,Department of Oncology and Hemato

[5] University of Milan and European Institute of Oncology, Oncology

[6] IRCCS,Department of Medical Oncology

[7] City of Hope Comprehensive Cancer Center,Department of Developmental Therapeutics, Lombardi Comprehensive Cancer Center

[8] Georgetown University,Department of Oncology, Montefiore Medical Center

[9] Albert Einstein College of Medicine,Department of Melanoma/Sarcoma Medical Oncology

[10] Rutgers Cancer Institute of New Jersey,Department of Medical Oncology

[11] MD Anderson Cancer Center Madrid,Department of Hematology/Oncology

[12] MD Anderson Banner Cancer Center,Precision Cancer Therapies (Phase I) Research Program, Experimental Therapeutics

[13] Ochsner,Division of Oncology, Department of Medicine, Huntsman Cancer Institute

[14] University of Utah,Center for Personalized Cancer Therapy, Moores Cancer Center

[15] Sarcoma Oncology Center,Department of Oncology

[16] University of California San Diego,Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Medicine

[17] Skåne University Hospital,Department of Medical Oncology

[18] University of Iowa,Department of Clinical Oncology, State Key Laboratory of Translational Oncology

[19] Peter MacCallum Cancer Centre,Division of Oncology, Department of Medicine

[20] Melbourne,Department of Medical Oncology

[21] The Chinese University of Hong Kong,Department of Palliative, Rehabilitation & Integrative Medicine, Division of Cancer Medicine

[22] Washington University in St. Louis,Department of Leukemia, Division of Cancer Medicine

[23] Dana- Farber Cancer Institute,Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine

[24] University of Texas MD Anderson Cancer Center,Division of Pediatrics

[25] University of Texas MD Anderson Cancer Center,MD Anderson Cancer Network

[26] University of Texas MD Anderson Cancer Center,undefined

[27] The University of Texas MD Anderson Cancer Center,undefined

[28] The University of Texas MD Anderson Cancer Center,undefined

来源：

Nature Reviews Clinical Oncology | 2021年 / 18卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A Correction to this paper has been published: https://doi.org/10.1038/s41571-021-00503-2.

引用

页码：320 / 320

共 50 条

[1] COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials (Mar, 10.1038/s41571-021-00487-z,, 2021)
Desai, Aakash
Gainor, Justin F.
Hegde, Aparna
Schram, Alison M.
Curigliano, Giuseppe
Pal, Sumanta
Liu, Stephen V.
Halmos, Balazs
Groisberg, Roman
Grande, Enrique
Dragovich, Tomislav
Matrana, Marc
Agarwal, Neeraj
Chawla, Sant
Kato, Shumei
Morgan, Gilberto
Kasi, Pashtoon M.
Solomon, Benjamin
Loong, Herbert H.
Park, Haeseong
Choueiri, Toni K.
Subbiah, Ishwaria M.
Pemmaraju, Naveen
Subbiah, Vivek
NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (05) : 320 - 320
[2] Exploration of potential risk factors for COVID-19 severity in patients participating in oncology clinical trials
Mohiuddin, Md
Kasahara, Kazuo
RESPIRATORY MEDICINE, 2021, 186
[3] Covid-19 and Clinical Trials in Oncology
Darling, H. S.
INDIAN JOURNAL OF CANCER, 2020, 57 (02) : 226 - 226
[4] Author Correction: Caring for patients with cancer in the COVID-19 era
Joris van de Haar
Louisa R. Hoes
Charlotte E. Coles
Kenneth Seamon
Stefan Fröhling
Dirk Jäger
Franco Valenza
Filippo de Braud
Luigi De Petris
Jonas Bergh
Ingemar Ernberg
Benjamin Besse
Fabrice Barlesi
Elena Garralda
Alejandro Piris-Giménez
Michael Baumann
Giovanni Apolone
Jean Charles Soria
Josep Tabernero
Carlos Caldas
Emile E. Voest
Nature Medicine, 2020, 26 (7) : 1146 - 1146
[5] Impact of COVID-19 on oncology clinical trials
Upadhaya, Samik
Yu, Jia Xin
Oliva, Cristina
Hooton, Megan
Hodge, Jeffrey
Hubbard-Lucey, Vanessa M.
NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (06) : 376 - 377
[6] COVID-19 vaccine immunity in oncology patients
Uslu, Gonca Hanedan
Rakici, Sema Yilmaz
Cicek, Aysegul Copur
Yazici, Zihni Acar
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2023, 124 (03): : 187 - 192
[7] COVID-19 Vaccine Guidance for Patients with Cancer in Mexico: Report From the Working Group of the Mexican Society of Oncology
Soto-Perez-de-Celis, Enrique
Arrieta, Oscar
Bargallo-Rocha, Enrique
Campos-Gomez, Saul
Chavarri-Guerra, Yanin
Chavez-Nogueda, Jessica
Gonzalez-Lara, Fernanda
Perez-Jacobo, Fernando
Martinez-Said, Hector
ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (02) : 223 - 227
[8] Oncology Clinical Trials During the COVID-19 Pandemic
Lara Gongora, Aline Bobato
Fontes Jardim, Denis Leonardo
Bastos, Diogo Assed
ONCOLOGY-NEW YORK, 2020, 34 (07): : 265 - 269
[9] Clinical Equipoise in COVID-19 Vaccine Candidate Trials
Dal-Re, Rafael
JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (09): : 1249 - 1250
[10] Author Correction: A global survey of potential acceptance of a COVID-19 vaccine
Jeffrey V. Lazarus
Scott C. Ratzan
Adam Palayew
Lawrence O. Gostin
Heidi J. Larson
Kenneth Rabin
Spencer Kimball
Ayman El-Mohandes
Nature Medicine, 2021, 27 (2) : 354 - 354

← 1 2 3 4 5 →